Abstract:Background: The physical and hormonal changes associated with central precocious puberty (CPP) and premature thelarche (PT) can be a significant source of stress for young girls, who may not be developmentally prepared to understand these changes. This study aims to investigate the presence of psychiatric disorders, assess depression, anxiety, coping difficulties, and the quality of life in girls diagnosed with PT, and compare them with idiopathic CPP (ICPP). Method: A total of 50 participants aged between 6-9 years (PT=33, ICPP=17) between July 2023 and December 2023 were included in the study. Both groups were evaluated by pediatric psychiatrists at a median of four months after diagnosis with ICPP or PT. Results: The PT group (n=33) had a mean age of 7.81 ± 0.76 years, while the ICPP group (n=17) had a mean age of 8.15 ± 0.35 years (P=0.091). In the PT group, 90.9% were at Tanner stage 2 and 9.1% were at Tanner stage 3 of pubertal development. In the ICPP group, 35.2% were at Tanner stage 2, 58.8% were at Tanner stage 3, and 5.8% were at Tanner stage 4. As expected, compared to the PT group, the ICPP group had taller heights, higher body weights, higher basal and stimulated luteinizing hormone (LH) levels, and elevated follicle-stimulating hormone (FSH) and estradiol (E2) levels (p<0.05). The total Revised Child Anxiety and Depression Scale (RCADS) score was higher in the PT group compared to the ICPP group (P=0.003). The physical Pediatric Quality of Life (PedsQL) score, psychosocial PedsQL score, and total PedsQL scores were all significantly lower in the PT group (P=0.034, P=0.016, P=0.019, respectively). The total Strengths and Difficulties Questionnaire (SDQ) score, used to evaluate difficulties in coping with challenges, was statistically similar in both groups (P=0.063). Subjects with higher anxiety and depression scores had lower quality of life (P<0.001; R=-0.639). There was also a statistically significant positive correlation between RCADS scores and SDQ scores (P<0.001; R=0.648). We did not find a significant correlation between RCADS scores and hormonal profiles or age. Conclusion: Despite the hypothalamic-pituitary-gonadal axis not being active, we believe that PT cases may experience psychological impacts due to body changes. While PT cases may not necessitate medical intervention from an endocrinological perspective, addressing their psychological needs can contribute to a healthier overall process for these individuals. The study's findings highlight the need for healthcare providers to monitor the psychological status of PT patients alongside their physical health. Larger-scale studies including control groups are needed to clearly evaluate the relationship between body changes and psychological symptoms.

Clinical Outcomes and Quality of Life in Children with Central Precocious Puberty: A Pragmatic Analysis

[Impact of Gonadotropin-Releasing Hormone Analogs on Body Mass Index in Girls with Idiopathic Central Precocious Puberty: a Long-Term Follow-Up Study].

[Long-Acting Gonadotropin-Releasing Hormone Analogue in Treatment of Idiopathic Central Precocious Puberty in Girls].

Long-Term Outcomes of Treatments for Central Precocious Puberty or Early and Fast Puberty in Chinese Girls

Evaluation of quality of life in children with precocious puberty

A survey of care pathway and health-related quality of life impact for children with central precocious puberty

Clinical analysis of 24 adolescents with precocious puberty associated with tumors

An open label, multicenter clinical trial that investigated the efficacy and safety of leuprorelin treatment of central precocious puberty in Chinese children

Effect of gonadotropin-releasing hormone agonist treatment in Vietnamese children with central precocious puberty

SUN-094 Long-Term Safety and Efficacy of Leuprorelin in Treating Central Precocious Puberty: A Large, Open-Label, Multicenter, Phase IV Study in China

Long-term health consequences of central precocious/early puberty (CPP) and treatment with Gn-RH analogue: a short update

Gonadotropin releasing hormone analogue therapy in girls with idiopathic precocious puberty/early-fast puberty: dynamics in adiposity indices, eating habits and quality of life

Retrospective evaluation of patients diagnosed with central precocious puberty who reached the final height

Optimal therapy of pubertal disorders in precocious/early puberty

Three Therapy Regimens and Their Cost-effectiveness for Girls With Central Precocious Puberty: A Real-World Clinical Study

Menstrual cycle, reproductive function, body mass index, and metabolic profiles of women with former central precocious puberty: 10–20-year longitudinal cohort study in southern Thailand

Approach to the Patient: Central Precocious Puberty

Assessing Psychiatric Evaluations in Premature Thelarche and Idiopathic Central Precocious Puberty Cases: Exploring Depression, Anxiety, Quality of Life, and Coping Challenges

Treated and untreated women with idiopathic precocious puberty: BMI evolution, metabolic outcome, and general health between third and fifth decades.

Long-Term Outcomes of Patients with Central Precocious Puberty due to Hypothalamic Hamartoma after GnRHa Treatment: Anthropometric, Metabolic, and Reproductive Aspects

Metabolic Outcomes, Bone Health, and Risk of Polycystic Ovary Syndrome in Girls with Idiopathic Central Precocious Puberty Treated with Gonadotropin-Releasing Hormone Analogues